Search research articles
Contact Us
Filters
Showing results (101-110 of 115) with videos related to
Page
of 12
Sort By:
Experimental and Clinical Immunogenetics
|
January 1, 1995
Fluorescent detection of microsatellite polymorphisms: properdin deficiency linked to PFC microsatellite
D Agardi, M Pigg, A G Sjöholm, et al.
British Journal of Cancer
|
December 19, 2007
Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome
A C J Ammerlaan, A Ararou, M P W A Houben, et al.
British Journal of Cancer
|
February 24, 2006
The association between antihypertensive drugs and glioma
M P W A Houben, J W W Coebergh, R M C Herings, et al.
Journal of Neuro-Oncology
|
December 14, 2017
Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial
Florien W Boele, Martin Klein, Irma M Verdonck-de Leeuw, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 29, 2006
Stable incidence of childhood and adult glioma in The Netherlands, 1989-2003
M P W A Houben, K K H Aben, J L J M Teepen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 20, 1999
Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas
M J van den Bent, J H Schellens, C J Vecht, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 31, 2013
New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951
Thierry Gorlia, Jean-Yves Delattre, Alba A Brandes, et al.
Neurology
|
October 22, 1998
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group
M J van den Bent, J M Kros, J J Heimans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2007
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study
Murielle E L Mauer, Martin J B Taphoorn, Andrew Bottomley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2010
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Martin J van den Bent, Hendrikus J Dubbink, Yannick Marie, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 115) with videos related to
Sort By:
Page
of 12
Experimental and Clinical Immunogenetics
|
January 1, 1995
Fluorescent detection of microsatellite polymorphisms: properdin deficiency linked to PFC microsatellite
D Agardi, M Pigg, A G Sjöholm, et al.
British Journal of Cancer
|
December 19, 2007
Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome
A C J Ammerlaan, A Ararou, M P W A Houben, et al.
British Journal of Cancer
|
February 24, 2006
The association between antihypertensive drugs and glioma
M P W A Houben, J W W Coebergh, R M C Herings, et al.
Journal of Neuro-Oncology
|
December 14, 2017
Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial
Florien W Boele, Martin Klein, Irma M Verdonck-de Leeuw, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 29, 2006
Stable incidence of childhood and adult glioma in The Netherlands, 1989-2003
M P W A Houben, K K H Aben, J L J M Teepen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 20, 1999
Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas
M J van den Bent, J H Schellens, C J Vecht, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 31, 2013
New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951
Thierry Gorlia, Jean-Yves Delattre, Alba A Brandes, et al.
Neurology
|
October 22, 1998
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group
M J van den Bent, J M Kros, J J Heimans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2007
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study
Murielle E L Mauer, Martin J B Taphoorn, Andrew Bottomley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2010
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Martin J van den Bent, Hendrikus J Dubbink, Yannick Marie, et al.
Page
of 12